Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer

Shuya Yano, Motoki Ninomiya, Hiroshi Sasaki, Tatsuo Umeoka, Masao Harano, Hideki Aoki, Tadashi Onoda, Shigehiro Shiozaki, Satoshi Ohno, Kenji Higaki, Norihisa Takakura

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We studied the significance of repeated intraperitoneal CDDP administration, as adjuvant chemotherapy, for the prevention of T3 and T4 gastric cancer. Fifty-two patients who had been operated as Curability B were divided into the following two groups, and the data on survival rate, median survival time and interval of "free of recurrence" were accumulated and analyzed. Group A consisted of nineteen patients treated with intraperitoneal CDDP administration and oral anticancer drugs. Group B were treated with systemic chemotherapy. Group A was superior to Group B in comparing the analyzed data. These results suggested that repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 advanced gastric cancer would improve survival rate.

Original languageEnglish
Pages (from-to)1720-1722
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume31
Issue number11
Publication statusPublished - Oct 2004
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer'. Together they form a unique fingerprint.

  • Cite this

    Yano, S., Ninomiya, M., Sasaki, H., Umeoka, T., Harano, M., Aoki, H., Onoda, T., Shiozaki, S., Ohno, S., Higaki, K., & Takakura, N. (2004). Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 31(11), 1720-1722.